HCPCS Level IIdrugActive
J1932
Inj, lanreotide, (cipla) 1mg
BETOS: O1E
Effective: 2022-10-01
Referenced in 2 policies
Description
Injection, lanreotide, (cipla), 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lanreotide
Manufacturer
Cipla USA, Inc.
HCPCS Dosage
1 MG
Billing Units
120.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.